1-6 of 6
Giuseppe Toffoli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer

Giuseppe Toffoli, Manish R. Sharma, Elena Marangon, Bianca Posocco, Elizabeth Gray, Quan Mai, Angela Buonadonna, Blase N. Polite, Gianmaria Miolo, Gianna Tabaro, Federico Innocenti
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (4): 918–924.
https://doi.org/10.1158/1078-0432.CCR-16-1012
Published: 14 February 2017
View articletitled, Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer
Open the PDF for Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Effect of TP53 Arg72Pro and MDM2 SNP309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and Survival

Giuseppe Toffoli, Paola Biason, Antonio Russo, Elena De Mattia, Erika Cecchin, Claudia Maria Hattinger, Michela Pasello, Marco Alberghini, Cristina Ferrari, Katia Scotlandi, Piero Picci, Massimo Serra
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (10): 3550–3556.
https://doi.org/10.1158/1078-0432.CCR-08-2249
Published: 18 May 2009
View articletitled, Effect of TP53 Arg72Pro and MDM2 SNP309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and Survival
Open the PDF for Effect of TP53 Arg72Pro and MDM2 SNP309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and Survival in another window
Journal Articles

Reply to the Letter to the Editor from Chowbay et al

Erika Cecchin, Giuseppe Corona, Giuseppe Toffoli
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (6): 1942.
https://doi.org/10.1158/1078-0432.CCR-05-2761
Published: 21 March 2006
View articletitled, Reply to the Letter to the Editor from Chowbay et al
Open the PDF for Reply to the Letter to the Editor from Chowbay et al in another window
Journal Articles

Carboxylesterase Isoform 2 mRNA Expression in Peripheral Blood Mononuclear Cells Is a Predictive Marker of the Irinotecan to SN38 Activation Step in Colorectal Cancer Patients

Erika Cecchin, Giuseppe Corona, Sara Masier, Paola Biason, Giulio Cattarossi, Sergio Frustaci, Angela Buonadonna, Annamaria Colussi, Giuseppe Toffoli
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 6901–6907.
https://doi.org/10.1158/1078-0432.CCR-05-0602
Published: 03 October 2005
View articletitled, Carboxylesterase Isoform 2 mRNA Expression in Peripheral Blood Mononuclear Cells Is a Predictive Marker of the Irinotecan to SN38 Activation Step in Colorectal Cancer Patients
Open the PDF for Carboxylesterase Isoform 2 mRNA Expression in Peripheral Blood Mononuclear Cells Is a Predictive Marker of the Irinotecan to SN38 Activation Step in Colorectal Cancer Patients in another window
Journal Articles

Methylenetetrahydrofolate Reductase 677 C → T Polymorphism and Risk of Proximal Colon Cancer in North Italy

Giuseppe Toffoli, Roberta Gafà, Antonio Russo, Giovanni Lanza, Riccardo Dolcetti, Franca Sartor, Massimo Libra, Alessandra Viel, Mauro Boiocchi
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (2): 743–748.
Published: 01 February 2003
View articletitled, Methylenetetrahydrofolate Reductase 677 C → T Polymorphism and Risk of Proximal Colon Cancer in North Italy
Open the PDF for Methylenetetrahydrofolate Reductase 677 C → T Polymorphism and Risk of Proximal Colon Cancer in North Italy in another window
Journal Articles

Dose-finding and Pharmacologic Study of Chronic Oral Idarubicin Therapy in Metastatic Breast Cancer Patients

Giuseppe Toffoli, Roberto Sorio, Paola Aita, Diana Crivellari, Giuseppe Corona, Alessandra Bearz, Isabel Robieux, Anna Maria Colussi, Franco Stocco, Mauro Boiocchi
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2279–2287.
Published: 01 June 2000
View articletitled, Dose-finding and Pharmacologic Study of Chronic Oral Idarubicin Therapy in Metastatic Breast Cancer Patients
Open the PDF for Dose-finding and Pharmacologic Study of Chronic Oral Idarubicin Therapy in Metastatic Breast Cancer Patients in another window